vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and KINGSTONE COMPANIES, INC. (KINS). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $56.4M, roughly 1.5× KINGSTONE COMPANIES, INC.). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs 22.8%, a 3.4% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 34.0%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 25.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
FDMT vs KINS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $56.4M |
| Net Profit | $19.4M | $14.8M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 32.7% |
| Net Margin | 22.8% | 26.2% |
| Revenue YoY | 8508900.0% | 34.0% |
| Net Profit YoY | 139.1% | 171.4% |
| EPS (diluted) | $0.43 | $1.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $56.4M | ||
| Q3 25 | $90.0K | $55.7M | ||
| Q2 25 | $15.0K | $52.3M | ||
| Q1 25 | $14.0K | $50.5M | ||
| Q4 24 | $1.0K | $42.1M | ||
| Q3 24 | $3.0K | $40.8M | ||
| Q2 24 | $5.0K | $36.5M | ||
| Q1 24 | $28.0K | $35.8M |
| Q4 25 | $19.4M | $14.8M | ||
| Q3 25 | $-56.9M | $10.9M | ||
| Q2 25 | $-54.7M | $11.3M | ||
| Q1 25 | $-48.0M | $3.9M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | $-43.8M | $7.0M | ||
| Q2 24 | $-35.0M | $4.5M | ||
| Q1 24 | $-32.4M | $1.4M |
| Q4 25 | 17.3% | 32.7% | ||
| Q3 25 | -67983.3% | 24.6% | ||
| Q2 25 | -396373.3% | 27.1% | ||
| Q1 25 | -383007.1% | 9.3% | ||
| Q4 24 | — | 15.9% | ||
| Q3 24 | -1704400.0% | 22.3% | ||
| Q2 24 | -849120.0% | 15.7% | ||
| Q1 24 | -136200.0% | 5.0% |
| Q4 25 | 22.8% | 26.2% | ||
| Q3 25 | -63195.6% | 19.5% | ||
| Q2 25 | -364386.7% | 21.5% | ||
| Q1 25 | -342657.1% | 7.7% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | -1461433.3% | 17.1% | ||
| Q2 24 | -699060.0% | 12.4% | ||
| Q1 24 | -115717.9% | 4.0% |
| Q4 25 | $0.43 | $1.09 | ||
| Q3 25 | $-1.01 | $0.74 | ||
| Q2 25 | $-0.98 | $0.78 | ||
| Q1 25 | $-0.86 | $0.27 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | $-0.79 | $0.55 | ||
| Q2 24 | $-0.63 | $0.37 | ||
| Q1 24 | $-0.66 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | — |
| Total DebtLower is stronger | — | $4.4M |
| Stockholders' EquityBook value | $505.7M | $122.7M |
| Total Assets | $566.7M | $453.4M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | — | ||
| Q3 25 | $305.1M | — | ||
| Q2 25 | $293.2M | — | ||
| Q1 25 | $321.4M | — | ||
| Q4 24 | $424.9M | — | ||
| Q3 24 | $501.9M | — | ||
| Q2 24 | $541.9M | — | ||
| Q1 24 | $525.9M | — |
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $4.8M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $17.3M | ||
| Q2 24 | — | $25.3M | ||
| Q1 24 | — | $25.3M |
| Q4 25 | $505.7M | $122.7M | ||
| Q3 25 | $369.0M | $107.7M | ||
| Q2 25 | $420.9M | $94.9M | ||
| Q1 25 | $469.7M | $82.2M | ||
| Q4 24 | $510.6M | $66.7M | ||
| Q3 24 | $552.9M | $59.7M | ||
| Q2 24 | $588.3M | $40.8M | ||
| Q1 24 | $600.6M | $35.7M |
| Q4 25 | $566.7M | $453.4M | ||
| Q3 25 | $424.0M | $428.6M | ||
| Q2 25 | $473.6M | $393.4M | ||
| Q1 25 | $515.7M | $385.4M | ||
| Q4 24 | $560.4M | $374.9M | ||
| Q3 24 | $604.0M | $347.0M | ||
| Q2 24 | $620.1M | $319.8M | ||
| Q1 24 | $629.9M | $318.3M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.05× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | 0.29× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $75.9M |
| Free Cash FlowOCF − Capex | $28.5M | $73.1M |
| FCF MarginFCF / Revenue | 33.5% | 129.5% |
| Capex IntensityCapex / Revenue | 0.1% | 5.0% |
| Cash ConversionOCF / Net Profit | 1.47× | 5.14× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $124.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $75.9M | ||
| Q3 25 | $-46.5M | $25.9M | ||
| Q2 25 | $-43.4M | $9.3M | ||
| Q1 25 | $-47.8M | $17.9M | ||
| Q4 24 | $-134.6M | $57.9M | ||
| Q3 24 | $-29.4M | $21.7M | ||
| Q2 24 | $-30.2M | $7.1M | ||
| Q1 24 | $-29.1M | $6.1M |
| Q4 25 | $28.5M | $73.1M | ||
| Q3 25 | $-46.6M | $25.3M | ||
| Q2 25 | $-43.4M | $8.7M | ||
| Q1 25 | $-48.4M | $17.0M | ||
| Q4 24 | $-138.4M | $55.6M | ||
| Q3 24 | $-31.2M | $21.0M | ||
| Q2 24 | $-30.6M | $6.6M | ||
| Q1 24 | $-29.8M | $5.6M |
| Q4 25 | 33.5% | 129.5% | ||
| Q3 25 | -51765.6% | 45.4% | ||
| Q2 25 | -289620.0% | 16.6% | ||
| Q1 25 | -345635.7% | 33.7% | ||
| Q4 24 | -13837100.0% | 132.1% | ||
| Q3 24 | -1038966.7% | 51.6% | ||
| Q2 24 | -611840.0% | 18.1% | ||
| Q1 24 | -106421.4% | 15.5% |
| Q4 25 | 0.1% | 5.0% | ||
| Q3 25 | 101.1% | 1.2% | ||
| Q2 25 | 440.0% | 1.1% | ||
| Q1 25 | 4507.1% | 1.7% | ||
| Q4 24 | 378600.0% | 5.6% | ||
| Q3 24 | 59266.7% | 1.7% | ||
| Q2 24 | 6980.0% | 1.4% | ||
| Q1 24 | 2535.7% | 1.5% |
| Q4 25 | 1.47× | 5.14× | ||
| Q3 25 | — | 2.38× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 4.60× | ||
| Q4 24 | — | 10.65× | ||
| Q3 24 | — | 3.12× | ||
| Q2 24 | — | 1.58× | ||
| Q1 24 | — | 4.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
